Sara Pri‐Chen
Impact in
- Urology top 10%
-
- Renal and related cancers
- Pluripotent Stem Cells Research
- Fibroblast Growth Factor Research
Papers in
-
- Renal and related cancers 8
- Fibroblast Growth Factor Research 5
- Bone Metabolism and Diseases 2
-
- Renal cell carcinoma treatment 5
- Co-authors
- Naphtali Savion (4 shared papers)S. Pitaru (4 shared papers)Benjamin Dekel (8 shared papers)Orit Harari‐Steinberg (8 shared papers)Franklin Lokiec (1 shared paper)Dorit Omer (5 shared papers)Ronald S. Goldstein (3 shared papers)Oren Pleniceanu (6 shared papers)
- Journals
- Connective Tissue Research (2 papers)EMBO Molecular Medicine (2 papers)Bone (2 papers)Stem Cell Reports (2 papers)Biomedicines (1 paper)
- Partner nations
- IsraelUnited StatesCanada
In The Last Decade
Sara Pri‐Chen
24 papers receiving 720 citations
Peers
Comparison fields: 5 of 72
- Urology 43
- Molecular Biology 417
- Genetics 58
- Pulmonary and Respiratory Medicine 137
- Pharmacology 66
Countries citing papers authored by Sara Pri‐Chen
This map shows the geographic impact of Sara Pri‐Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Pri‐Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Pri‐Chen more than expected).
Fields of papers citing papers by Sara Pri‐Chen
This network shows the impact of papers produced by Sara Pri‐Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Pri‐Chen. The network helps show where Sara Pri‐Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Sara Pri‐Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 97 | |
| 2 | 1998 | 95 | |
| 3 | 2012 | 72 | |
| 4 | 2016 | 59 | |
| 5 | 2013 | 52 | |
| 6 | 2016 | 43 | |
| 7 | 2014 | 38 | |
| 8 | 2000 | 29 | |
| 9 | 2001 | 26 | |
| 10 | 2018 | 25 | |
| 11 | 2004 | 25 | |
| 12 | 2020 | 24 | |
| 13 | Decreased serum cholesterol level after snake bite (Vipera palaestinae) as a marker of severity of envenomation. | 1993 | 24 |
| 14 | 2002 | 18 | |
| 15 | 1985 | 18 | |
| 16 | 2012 | 17 | |
| 17 | 2017 | 17 | |
| 18 | 2001 | 12 | |
| 19 | 2008 | 12 | |
| 20 | 1986 | 12 |
About Sara Pri‐Chen
Sara Pri‐Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Pharmacology and Genetics, having authored 24 papers that have together received 732 indexed citations. Recurring topics across this work include Renal and related cancers (8 papers), Renal cell carcinoma treatment (5 papers), Fibroblast Growth Factor Research (5 papers), Retinopathy of Prematurity Studies (3 papers), Mesenchymal stem cell research (3 papers), Liver physiology and pathology (2 papers), Cannabis and Cannabinoid Research (2 papers) and Bone Metabolism and Diseases (2 papers). The work is most often cited by research in Urology (43 citations), Molecular Biology (417 citations), Genetics (58 citations), Pulmonary and Respiratory Medicine (137 citations) and Pharmacology (66 citations). Sara Pri‐Chen has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Naphtali Savion, S. Pitaru, Benjamin Dekel, Orit Harari‐Steinberg, Franklin Lokiec, Dorit Omer, Ronald S. Goldstein, Oren Pleniceanu, Einav Vax and Shlomo Kotev‐Emeth. Their work appears in journals such as Connective Tissue Research, EMBO Molecular Medicine, Bone, Stem Cell Reports and Biomedicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.